NEW YORK, Jan. 12, 2018 /PRNewswire/ — WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ACHC, MD, ANTM, and DVA which can be accessed for free by signing up to www.wallstequities.com/registration. Focus has been shifted by WallStEquities.com on the Healthcare sector, which provides goods and services to treat patients with curative, preventive, rehabilitative, and palliative care. Lined up for scanning this morning are: Acadia Healthcare Co. Inc. (NASDAQ: ACHC), MEDNAX Inc. (NYSE: MD), Anthem Inc. (NYSE: ANTM), and DaVita Inc. (NYSE: DVA). All you have to do is sign up today for this free limited time offer by clicking the link below.
Franklin, Tennessee headquartered Acadia Healthcare Co. Inc.’s stock finished Thursday’s session 4.18% higher at $34.38 with a total trading volume of 845,070 shares. Over the last month, the Company’s shares have advanced 7.10%. The stock is trading above its 50-day moving average by 9.90%. Moreover, shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the US, the UK, and Puerto Rico, have a Relative Strength Index (RSI) of 66.37. Get the full research report on ACHC for free by clicking below at:
Shares in Sunrise, Florida headquartered MEDNAX Inc. rose 1.44%, ending yesterday’s session at $54.17 with a total trading volume of 654,100 shares. The stock has gained 5.33% in the past month and 25.13% in the previous three months. The Company’s shares are trading 9.13% above their 50-day moving average and 4.60% above their 200-day moving average. Moreover, shares of MEDNAX, which together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 65.88.
On December 13th, 2017, research firm Piper Jaffray initiated an ‘Overweight’ rating on the Company’s stock, with a target price of $58 per share.
On January 10th, 2018, MEDNAX announced its acquisition of Tri-Valley Neonatal Medical Group, Inc., a private neonatology physician practice in Van Nuys, California that provides neonatology and newborn nursery services. This was a cash transaction, and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed. Find your free research report MD at: